Anthrax: A zoonosis and a biological weapon

Infectious Diseases in Clinical Practice

Volumn 8, Issue 6, 1999, Pages 270-273

  Shlyakhov, Elie ^a   Rubinstein, Ethan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANTHRAX TOXIN; ANTIBIOTIC AGENT; BENZETHONIUM CHLORIDE; CALMODULIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOKINE; DEXTRO GLUTAMIC ACID; DOXYCYCLINE; FORMALDEHYDE; GENTAMICIN; LOMEFLOXACIN; METALLOPROTEINASE; MINOCYCLINE; PEFLOXACIN; PENICILLIN G; PROCAINE PENICILLIN; RADICAL; STREPTOMYCIN; TETRACYCLINE; VACCINE; ZINC;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LETHAL GENE; LIFE CYCLE; NONHUMAN; ORAL DRUG ADMINISTRATION; SHORT SURVEY; VACCINATION; ZOONOSIS;

EID: 0032791243     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199908000-00002     Document Type: Short Survey

References (19)

1. Leppla SH. Anthrax toxins. Bacterial toxins and virulence factors in disease. In: Moss J, Vaugham M, Iglewski B, et al., editors. Handhook of natural toxins, vol 8. New York: Marcel Dekker; 1995. p. 543-72.
2. Shlyakhov EN, Litvine VY. Principes ecologo-epidemiologiques de classification des maladies infectieuses. Med Mal Infect 1988;18:893-4.
3. Hugh-Jones M. 1996 global anthrax report. In: Abstract book of the 3rd International Conference on Anthrax; 1998 Sep 7-10; Plymouth, United Kingdom. United Kingdom: DERA, Porton Down, and The Society for Applied Microbiology; 1988. p.1.
4. Shlyakhov EN, Prisakari VI. Epidemiological survey on anthrax [in Russian]. Kishinev: Shtiintza, 1989. p. 80.
5. LaForce FM. Anthrax. Clin Infect Dis 1994;19:1009-14.
6. Shlyakhov EN, Rubinstein E. Evaluation of the anthrax in skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis 1996;15:242-5.
7. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266: 1202-8.
8. Walker DH, Yampolska O, Grinberg LM. Death at Sverdlovsk: what have we learned? Am J Pathol 1994;144: 1135-41.
9. Grinberg LM, Abramova AA. Pathology of anthrax sepsis according to materials of the infectious outbreak in 1979 in Sverdlovsk (various aspects of morpho-, pathoand thanatogenesis) [in Russian]. Arkh Patol 1993;55: 23-6.
10. Burnet MF. Natural history of infectious diseases. 3rd ed. United Kingdom: Cambridge University Press; 1962. p. 149-50.
11. Hanna P. Anthrax pathogenesis and host response. Curr Top Microbiol Immunol 1998;225:13-35.
12. Duesbury NS, Webb CP, Leppla SH, et al. Proteolytic inactivation of Map-kinase-kinase by anthrax lethal factor. Science 1998;280:734-7.
13. Diakov SI, Katsalukha VV, Lebedeva IK, et al. Comparative evaluation of fluoroquinolones efficacy in experimental anthrax infection [in Russian]. Antibiot Khimioter 1994;39:15-9.
14. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278:399-441.
15. Pomerantse AP, Shishkova NA, Marinin LI. Comparison of the therapeutic effect of the tetracycline group in the treatment of anthrax caused by a strain inheriting tetgene of plasmid pBC16 [in Russian]. Antibiot Khimioter 1992;37:31-4.
16. Ivins BE, Fellows PF, Pitt MLM, et al. Efficacy of anthrax vaccines against aerosol challenge. Salisbury Med Bull 1996;87(Suppl):125-6
17. Pitt MLM, Ivins BE, Estep JE, et al. Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalational anthrax. Salisbury Med Bull 1996;87(Suppl):130.
18. Nass M. Anthrax vaccine safety and efficacy. ProMed Mail (Internet); 27 March 1998, 980103203307.
19. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and post attack intervention programs justifiable? Emerg Infect Dis 1997;3:83-94.